US Patent 8962656 CCR2 antagonists
Patent 8962656 was granted and assigned to Boehringer Ingelheim on February, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 26, 2011
Date of Patent
February 24, 2015
Patent Application Number
13700752
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8962656 CCR2 antagonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.